KalVista rises after licensing deal with Kaken for lead asset in Japan
KalVista Pharmaceuticals (KALV) stock rises as the company secures a $22M+ licensing deal with Kaken Pharma (KKPCF) for Japan ...
Recession-Proofing Your Portfolio
Trump's Liberation Day marks the end of the free-trade era. Check out companies or asset classes that may perform well during ...
3 Promising Penny Stocks With Market Caps Under $300M
Amid ongoing market volatility and tariff uncertainties, the S&P 500 and Dow Jones Industrial Average have experienced significant declines, while the Nasdaq Composite showed a slight increase. For ...
Top 3 Dividend Stocks To Enhance Your Portfolio
As the U.S. markets experience volatility amid ongoing tariff uncertainties, with major indices like the S&P 500 and Dow Jones showing mixed performances, investors are increasingly seeking stability ...